Dr Alicia Chan is a Consultant Cardiologist specializing in Heart Failure and Device Implantation in Adelaide, South Australia. She had completed training in Adelaide, Edinburgh and Calgary. She currently leads the Heart Failure Services at The Queen Elizabeth Hopsital, and contributed to the 2022 Consensus on HFrEF Phamacotherapy, Transition of Care and Management of Acute Heart Failure in Australia publications. She is currently a Board member of CSANZ and Heart Foundation and continues to be active in teaching through the University of Adelaide.

Muthiah Vaduganathan, MD MPH FACC FHFA is a cardiologist and clinical trialist at Brigham and Women’s Hospital and Harvard Medical School. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He serves as an Associate Editor of JACC and as US national ambassador to the ESC Heart Failure Association. His research focuses on drug development, clinical trials, and implementation of cardio-kidney-metabolic therapies. He has authored or co-authored more than 950 peer-reviewed publications and is recognized as a Clarivate Highly Cited Researcher. He participates on study leadership of ongoing advanced-phase trials in cardio-kidney-metabolism and heart failure.